Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07481500
What this trial is testing

Speculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: Pain, Procedure Time, Patient Satisfaction, and Safety

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Diabetic Macular EdemaRetinal Vein Occlusion+2 more
Jakkrit Juhong 129
Not applicableStudy completedNCT01933152
What this trial is testing

Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Bayer 137
Testing effectiveness (Phase 2)Ended earlyNCT02214628
What this trial is testing

Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 101
Testing effectiveness (Phase 2)Study completedNCT01945866
What this trial is testing

Phase II Combination Steroid and Anti-VEGF for Persistent DME

Who this might be right for
Diabetic Macular Edema
Jaeb Center for Health Research 129
Early research (Phase 1)Ended earlyNCT03396861
What this trial is testing

Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept

Who this might be right for
Irvine-Gass Syndrome
Tufts Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT03071055
What this trial is testing

Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF

Who this might be right for
Exudative Age Related Macular Degeneration
Southeast Clinical Research Associates, LLC 20
Not applicableWithdrawnNCT01470430
What this trial is testing

VEGF In Systemic Circulation Of ROP-infants

Who this might be right for
Retinopathy of Prematurity (ROP)
University Hospital Freiburg
Testing effectiveness (Phase 2)Study completedNCT02713204
What this trial is testing

Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection

Who this might be right for
Neovascular Age-Related Macular Degeneration
Regeneron Pharmaceuticals 365
Post-approval studies (Phase 4)UnknownNCT02462304
What this trial is testing

To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema

Who this might be right for
Diabetic Macula Edema
The University of Hong Kong 60
Testing effectiveness (Phase 2)Study completedNCT00336323
What this trial is testing

Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)

Who this might be right for
Diabetic Retinopathy
Jaeb Center for Health Research 121
Not applicableStudy completedNCT07096713
What this trial is testing

Brolucizumab Versus Aflibercept on Visual and Anatomical Outcomes in Diabetic Macular Edema

Who this might be right for
Anti-VEGF Therapy
Benha University 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT05844150
What this trial is testing

PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC

Who this might be right for
SCLC
Biotheus Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06840834
What this trial is testing

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Who this might be right for
Pleural Mesotheliomas
Intergroupe Francophone de Cancerologie Thoracique 38
Testing effectiveness (Phase 2)Study completedNCT01753713
What this trial is testing

Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
Manmeet Ahluwalia, MD 33
Not applicableLooking for participantsNCT07642960
What this trial is testing

Fine-needle Diathermy Combined With Subconjunctival Bevacizumab for Corneal Neovascularization

Who this might be right for
Corneal Neovascularisation
HoChiMinh City Eye Hospital 51
Not applicableStudy completedNCT06881433
What this trial is testing

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 1,649
Not applicableUnknownNCT05728476
What this trial is testing

Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaPars Plana VitrectomyConbercept
Tianjin Medical University Eye Hospital 102
Testing effectiveness (Phase 2)Study completedNCT00423332
What this trial is testing

Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
AstraZeneca 105
Not applicableStudy completedNCT07514559
What this trial is testing

Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases

Who this might be right for
Age Related Macular Degeneration (ARMD)Retinal Vein Occlusion (RVO)Diabetic Macular Edema (DME)
Hospital Hietzing 393
Not applicableStudy completedNCT02762188
What this trial is testing

Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)

Who this might be right for
Age-Related Macular Degeneration
Brugmann University Hospital 501
Next Page